Clinical Trials
16 trialsNCT05703516 2026-06-01
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Novartis
Recruiting
NCT06843629 2026-05-28
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Recruiting
NCT05191485 2026-04-30
Shared Decision Making in Patients With Lung Cancer
Sichuan Cancer Hospital and Research Institute
Recruiting
NCT06181812 2026-04-08
Pathogenic Variants in Genes Associated With Lung Adenocarcinoma
Instituto Nacional de Cancerologia de Mexico
Recruiting
NCT05665504 2026-04-01
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Recruiting
NCT07012759 2026-03-05
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Fu Jen Catholic University
Recruiting
NCT05517811 2025-01-28
TEG
University of Colorado, Denver
Recruiting
NCT06745830 2024-12-20
Lymph Node Pathologic Grading Strategy
Fudan University
Recruiting
NCT05925764 2024-10-21
WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Recruiting
NCT05830812 2024-09-19
Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Recruiting
NCT04566432 2024-07-18
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
Geneplus-Beijing Co. Ltd.
Recruiting
NCT06441357 2024-06-04
Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter
Tang-Du Hospital
Recruiting
NCT06255197 2024-02-16
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
NCT05550961 2023-10-23
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT05838053 2023-07-27
Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Shanghai Pulmonary Hospital, Shanghai, China
Recruiting
NCT05537922 2023-01-06
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting